Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic activity, ion channels remain closed, blocking neuromuscular transmission and causing muscle relaxation.
The antagonistic effect can be overcome by increasing acetylcholine concentration using acetylcholinesterase (AChE) inhibitors. Elevated acetylcholine displaces the blocker, restoring neuromuscular transmission. However, the blockers can directly block Na+ channels at high doses, resulting in irreversible neuromuscular blockade unresponsive to AChE inhibitors.
来自章节 7:
Now Playing
Skeletal Muscle Relaxants
1.1K Views
Skeletal Muscle Relaxants
2.2K Views
Skeletal Muscle Relaxants
2.2K Views
Skeletal Muscle Relaxants
298 Views
Skeletal Muscle Relaxants
383 Views
Skeletal Muscle Relaxants
918 Views
Skeletal Muscle Relaxants
248 Views
Skeletal Muscle Relaxants
563 Views
Skeletal Muscle Relaxants
283 Views
Skeletal Muscle Relaxants
403 Views
Skeletal Muscle Relaxants
808 Views
Skeletal Muscle Relaxants
2.8K Views
Skeletal Muscle Relaxants
484 Views
版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。